SCHEMBL6661557

SCHEMBL6661557

c1ccc(-c2ccc3c(ccn3-c3cccnc3)c2)nc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.53
CYP2A6 P11509 2/20 0.49
TGFBR1 P36897 4/20 0.42
TGFBR2 P37173 1/20 0.42
GRM5 P41594 3/20 0.42
CYP11B1 P15538 2/20 0.41
CYP11B2 P19099 2/20 0.41
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
PKM P14618 1/20 0.39
TSHR P16473 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP2E1 P05181 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAP3K20 Q9NYL2 1/20 0.39
IRAK4 Q9NWZ3 1/20 0.39
HTR1A P08908 1/20 0.39
HTR7 P34969 1/20 0.39
GRM1 Q13255 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6655119 0.83 CYP11B2 (0.51) CYP2A6CYP11B1CYP11B2CYP2E1CYP3A4
SCHEMBL6846125 0.82 CYP11B2 (0.59) MAPTCYP2A6CYP11B1CYP11B2CYP3A4
SCHEMBL6960921 0.82 KCNH2 (0.49) MAPTTGFBR1GRM5NPC1RAB9A
SCHEMBL22515748 0.81 CYP11B2 (0.49) CYP2A6CYP11B1CYP11B2CYP2E1CYP3A4
SCHEMBL6846113 0.81 CYP11B2 (0.48) MAPTCYP2A6CYP11B1CYP11B2CYP2E1
SCHEMBL6657591 0.80 CYP11B2 (0.56) CYP2A6CYP11B1CYP11B2CYP3A4KDM4C
SCHEMBL6652718 0.80 CYP2E1 (0.43) MAPTCYP2A6CYP11B1CYP11B2CYP2E1
SCHEMBL22515743 0.79 CYP11B2 (0.53) CYP2A6CYP11B1CYP11B2
SCHEMBL6682744 0.79 CYP11B2 (0.50) MAPTCYP2A6CYP11B1CYP11B2CYP2E1
SCHEMBL6656090 0.78 CYP11B2 (0.50) MAPTCYP11B1CYP11B2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432698-A2 SUBSTITUTED 3-PYRIDYL INDOLES AND INDAZOLES AS C17,20 LYASE INHIBITORS Bayer Pharmaceuticals Corporation (US) 2004-06-30 EP disclosed
WO-2003027094-A2 SUBSTITUTED 3-PYRIDYL INDOLES AND INDAZOLES AS C17,20 LYASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed